MARKET

GNMX

GNMX

Aevi Genomic Med
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.1399
+0.0029
+2.12%
Closed 16:00 10/11 EDT
OPEN
0.1438
PREV CLOSE
0.1370
HIGH
0.1450
LOW
0.1380
VOLUME
417.58K
TURNOVER
--
52 WEEK HIGH
1.320
52 WEEK LOW
0.1328
MARKET CAP
9.06M
P/E (TTM)
-0.3996
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GNMX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

GNMX News

  • The Daily Biotech Pulse: D-Day For Clinuvel, Qiagen Warns Of Q3 Shortfall, Prevail Announces Gene Therapy Collaboration
  • Benzinga.5d ago
  • The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines
  • Benzinga.10/01 12:10
  • 17 Healthcare Stocks Moving In Monday's Pre-Market Session
  • Benzinga.08/12 12:35
  • 31 Healthcare Stocks Moving In Today's Pre-Market Session
  • Benzinga.08/09 13:00

More

Industry

Biotechnology & Medical Research
+0.89%
Pharmaceuticals & Medical Research
+0.89%

Hot Stocks

Name
Price
%Change

About GNMX

Aevi Genomic Medicine, Inc., formerly Medgenics, Inc., is focused on genomic medicine. The Company is engaged in unlocking the potential of genomic medicine to translate genetic discoveries into therapies. The Company is engaged in developing therapies for children and adults with pediatric onset life altering diseases. The Company's product candidates include AEVI-001 and AEVI-002. The Company's research and development efforts leverage an internal genomics platform and a collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). .
More

Webull offers Aevi Genomic Medicine Inc (GNMX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.